{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T01:25:10Z","timestamp":1787189110775,"version":"build-2736575974"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anusandhan National Research Foundation","award":["CRG\/2021\/000190"],"award-info":[{"award-number":["CRG\/2021\/000190"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55793-2","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:26:28Z","timestamp":1780975588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesoporous silica nanoparticle-mediated delivery of a synergistic 5-miRNA combination inhibits HSV-2 infection"],"prefix":"10.1038","volume":"16","author":[{"given":"Debashree","family":"Dass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwesha","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NS","family":"Suneesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artha","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Arif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobhit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"55793_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/v16121928","volume":"16","author":"A Banerjee","year":"2024","unstructured":"Banerjee, A. et al. The \u2018Oma\u2019s of the Gammas\u2014Cancerogenesis by \u03b3-Herpesviruses. Viruses 16, 1928 (2024).","journal-title":"Viruses"},{"key":"55793_CR2","unstructured":"WHO. Herpes Simplex Virus. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/herpes-simplex-virus (2025)."},{"issue":"57","key":"55793_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/QAI.0b013e31821acb5","volume":"1999","author":"RV Barnabas","year":"2011","unstructured":"Barnabas, R. V. et al. Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study). J. Acquir. Immune Defic. Syndr. 1999(57), 238\u2013244 (2011).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"55793_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fmicb.2020.00733","volume":"11","author":"A Banerjee","year":"2020","unstructured":"Banerjee, A., Kulkarni, S. & Mukherjee, A. Herpes simplex virus: the hostile guest that takes over your home. Front. Microbiol. 11, 733 (2020).","journal-title":"Front. Microbiol."},{"key":"55793_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1128\/AAC.00615-10","volume":"55","author":"J Piret","year":"2011","unstructured":"Piret, J. & Boivin, G. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob. Agents Chemother. 55, 459\u2013472 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55793_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115322","volume":"206","author":"HH Schalkwijk","year":"2022","unstructured":"Schalkwijk, H. H., Snoeck, R. & Andrei, G. Acyclovir resistance in herpes simplex viruses: prevalence and therapeutic alternatives. Biochem. Pharmacol. 206, 115322 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"55793_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/v15020429","volume":"15","author":"D Dass","year":"2023","unstructured":"Dass, D. et al. miRNAs in Herpesvirus infection: powerful regulators in small packages. Viruses 15, 429 (2023).","journal-title":"Viruses"},{"key":"55793_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38473-8","volume":"9","author":"U Mukhopadhyay","year":"2019","unstructured":"Mukhopadhyay, U. et al. Synchronized orchestration of miR-99b and let-7g positively regulates rotavirus infection by modulating autophagy. Sci. Rep. 9, 1318 (2019).","journal-title":"Sci. Rep."},{"key":"55793_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/v15112206","volume":"15","author":"P Pawar","year":"2023","unstructured":"Pawar, P. et al. MiR-155 negatively regulates anti-viral innate responses among HIV-infected progressors. Viruses 15, 2206 (2023).","journal-title":"Viruses"},{"key":"55793_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jare.2020.11.013","volume":"30","author":"T Abu-Izneid","year":"2021","unstructured":"Abu-Izneid, T. et al. Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections. J. Adv. Res. 30, 133\u2013145 (2021).","journal-title":"J. Adv. Res."},{"key":"55793_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/med.22073","volume":"45","author":"SZ Bahojb Mahdavi","year":"2025","unstructured":"Bahojb Mahdavi, S. Z. et al. A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection. Med. Res. Rev. 45, 349\u2013425 (2025).","journal-title":"Med. Res. Rev."},{"key":"55793_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810242","volume":"23","author":"U Kansakar","year":"2022","unstructured":"Kansakar, U. et al. miR-142 targets TIM-1 in human endothelial cells: potential implications for stroke, COVID-19, zika, ebola, dengue, and other viral infections. Int. J. Mol. Sci. 23, 10242 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"55793_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/OLQ.0b013e3182367c4c","volume":"39","author":"NJ Veldhuijzen","year":"2012","unstructured":"Veldhuijzen, N. J. et al. Prevalence and concordance of HPV, HIV, and HSV-2 in Heterosexual Couples in Kigali. Rwanda. Sex. Transm. Dis. 39, 128\u2013135 (2012).","journal-title":"Rwanda. Sex. Transm. Dis."},{"key":"55793_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/path.2873","volume":"224","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J. Pathol. 224, 484\u2013495 (2011).","journal-title":"J. Pathol."},{"key":"55793_CR15","first-page":"85","volume":"7","author":"P Poltronieri","year":"2018","unstructured":"Poltronieri, P., Sun, B., Huang, K.-Y., Chang, T.-H. & Lee, T.-Y. State-of-the-Art on viral microRNAs in HPV infection and cancer development. MicroRNA Shariqah United Arab Emir. 7, 85\u201391 (2018).","journal-title":"MicroRNA Shariqah United Arab Emir."},{"key":"55793_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.virol.2015.09.016","volume":"486","author":"P Wang","year":"2015","unstructured":"Wang, P. et al. Two cellular micrornas, miR-196b and miR-1290, contribute to HIV-1 latency. Virology 486, 228\u2013238 (2015).","journal-title":"Virology"},{"key":"55793_CR17","doi-asserted-by":"publisher","first-page":"1602965","DOI":"10.3389\/fcimb.2025.1602965","volume":"15","author":"D Dass","year":"2025","unstructured":"Dass, D., Banerjee, A., More, A. & Mukherjee, A. MicroRNAs as regulators of NLRP3 inflammasome activation in herpes simplex virus type 2 infection. Front. Cell. Infect. Microbiol. 15, 1602965 (2025).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"55793_CR18","doi-asserted-by":"crossref","unstructured":"Chen, S. et al. Neuronal miR-138 Represses HSV-2 Lytic Infection by Regulating Viral and Host Genes with Mechanistic Differences from HSV-1. J. Virol. 96, e00349-22.","DOI":"10.1128\/jvi.00349-22"},{"key":"55793_CR19","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.1038\/s41598-017-18225-w","volume":"7","author":"HAM Hussein","year":"2017","unstructured":"Hussein, H. A. M. & Akula, S. M. miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1). Sci. Rep. 7, 17972 (2017).","journal-title":"Sci. Rep."},{"key":"55793_CR20","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/vaccines11091488","volume":"11","author":"A Banerjee","year":"2023","unstructured":"Banerjee, A. et al. Combinatorial effects of miRNAs in HSV-2 infection of macrophages: an in silico and in vitro integration approach. Vaccines 11, 1488 (2023).","journal-title":"Vaccines"},{"key":"55793_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1743-422X-2-59","volume":"2","author":"S Ellermann-Eriksen","year":"2005","unstructured":"Ellermann-Eriksen, S. Macrophages and cytokines in the early defence against herpes simplex virus. Virol. J. 2, 59 (2005).","journal-title":"Virol. J."},{"key":"55793_CR22","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/nano13111755","volume":"13","author":"S Hosseinpour","year":"2023","unstructured":"Hosseinpour, S., Dai, H., Walsh, L. J. & Xu, C. Mesoporous core-cone silica nanoparticles can deliver miRNA-26a to macrophages to exert immunomodulatory effects on osteogenesis in vitro. Nanomater. Basel Switz. 13, 1755 (2023).","journal-title":"Nanomater. Basel Switz."},{"key":"55793_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/ph10040088","volume":"10","author":"Y Cao","year":"2017","unstructured":"Cao, Y., Teng, J. & Selbo, J. Amorphous solid dispersion of epigallocatechin gallate for enhanced physical stability and controlled release. Pharmaceuticals 10, 88 (2017).","journal-title":"Pharmaceuticals"},{"key":"55793_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106293","volume":"101","author":"S Tyagi","year":"2024","unstructured":"Tyagi, S., Gaikwad, S. Y., Chandane-Tak, M., Mukherjee, A. & Kumar, S. Optimization of dolutegravir and epigallocatechin gallate loaded nanoemulsion for enhanced oral delivery in NeuroAIDS management. J. Drug Deliv. Sci. Technol. 101, 106293 (2024).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"55793_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.56","volume":"5","author":"M Perepelyuk","year":"2016","unstructured":"Perepelyuk, M. et al. Biodistribution and pharmacokinetics study of siRNA-loaded anti-NTSR1-mAb-functionalized novel hybrid nanoparticles in a metastatic orthotopic murine lung cancer model. Mol. Ther. Nucleic Acids 5, e282 (2016).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"55793_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06054","volume":"4","author":"C Petro","year":"2015","unstructured":"Petro, C. et al. Herpes simplex type virus deleted in glycoprotein D protects against vaginal, skin and neural disease. eLife 4, e06054 (2015).","journal-title":"eLife"},{"key":"55793_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/infdis\/jit472","volume":"209","author":"B Nixon","year":"2014","unstructured":"Nixon, B. et al. Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease. J. Infect. Dis. 209, 510\u2013522 (2014).","journal-title":"J. Infect. Dis."},{"key":"55793_CR28","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1128\/JVI.07203-11","volume":"86","author":"S Awasthi","year":"2012","unstructured":"Awasthi, S. et al. Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread. J. Virol. 86, 4586\u20134598 (2012).","journal-title":"J. Virol."},{"key":"55793_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101127","volume":"12","author":"AM Mahant","year":"2024","unstructured":"Mahant, A. M., Gualdron, T. J. & Herold, B. C. Novel mouse model of recurrent sublethal herpes simplex virus infection recapitulates human antibody responses to primary and chronic infection. Vaccines 12, 1127 (2024).","journal-title":"Vaccines"},{"key":"55793_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","volume":"190","author":"LM Ensign","year":"2014","unstructured":"Ensign, L. M., Cone, R. & Hanes, J. Nanoparticle-based drug delivery to the vagina: a review. J. Control. Release 190, 500\u2013514 (2014).","journal-title":"J. Control. Release"},{"key":"55793_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22050782","volume":"22","author":"W Cha","year":"2017","unstructured":"Cha, W. et al. Mesoporous silica nanoparticles as carriers for intracellular delivery of nucleic acids and subsequent therapeutic applications. Molecules 22, 782 (2017).","journal-title":"Molecules"},{"key":"55793_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106087","volume":"100","author":"S Iranpour","year":"2024","unstructured":"Iranpour, S., Abnous, K., Taghdisi, S. M. & Saljooghi, A. S. Towards the preparation of smart drug delivery platforms for colorectal cancer therapy: Biocompatible and targeted mesoporous silica nanoparticles with the deferiprone-copper complex gatekeeper. J. Drug Deliv. Sci. Technol. 100, 106087 (2024).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"55793_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.829796","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Applications and biocompatibility of mesoporous silica nanocarriers in the field of medicine. Front. Pharmacol. 13, 829796 (2022).","journal-title":"Front. Pharmacol."},{"key":"55793_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/pharmaceutics12050432","volume":"12","author":"RR Castillo","year":"2020","unstructured":"Castillo, R. R., Lozano, D. & Vallet-Reg\u00ed, M. Mesoporous silica nanoparticles as carriers for therapeutic biomolecules. Pharmaceutics 12, 432 (2020).","journal-title":"Pharmaceutics"},{"key":"55793_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69995-9","volume":"10","author":"I Greco","year":"2020","unstructured":"Greco, I. et al. Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. Sci. Rep. 10, 13206 (2020).","journal-title":"Sci. Rep."},{"key":"55793_CR36","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s11033-020-05276-y","volume":"47","author":"P Sarkar","year":"2020","unstructured":"Sarkar, P. et al. Antioxidant molecular mechanism of adenosyl homocysteinase from cyanobacteria and its wound healing process in fibroblast cells. Mol. Biol. Rep. 47, 1821\u20131834 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"55793_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6009309","volume":"2022","author":"A Sartaj","year":"2022","unstructured":"Sartaj, A. et al. Ribociclib nanostructured lipid carrier aimed for breast cancer: Formulation optimization, attenuating in vitro specification, and in vivo scrutinization. BioMed Res. Int. 2022, 1\u201324 (2022).","journal-title":"BioMed Res. Int."},{"key":"55793_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jnutbio.2013.10.002","volume":"25","author":"S Wang","year":"2014","unstructured":"Wang, S. et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J. Nutr. Biochem. 25, 363\u2013376 (2014).","journal-title":"J. Nutr. Biochem."},{"key":"55793_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/v16091383","volume":"16","author":"D Dass","year":"2024","unstructured":"Dass, D. et al. HSV-2 manipulates autophagy through interferon pathway: a strategy for viral survival. Viruses 16, 1383 (2024).","journal-title":"Viruses"},{"key":"55793_CR40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener, C., Keller, A. & Meese, E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 38, 613\u2013626 (2022).","journal-title":"Trends Genet."},{"key":"55793_CR41","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1093\/nar\/gkz638","volume":"47","author":"X Lai","year":"2019","unstructured":"Lai, X., Eberhardt, M., Schmitz, U. & Vera, J. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer. Nucleic Acids Res. 47, 7753\u20137766 (2019).","journal-title":"Nucleic Acids Res."},{"key":"55793_CR42","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/nar\/gkn109","volume":"36","author":"YP Liu","year":"2008","unstructured":"Liu, Y. P., Haasnoot, J., Ter Brake, O., Berkhout, B. & Konstantinova, P. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res. 36, 2811\u20132824 (2008).","journal-title":"Nucleic Acids Res."},{"key":"55793_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01651","volume":"8","author":"C Liu","year":"2017","unstructured":"Liu, C., Liang, Z. & Kong, X. Efficacy analysis of combinatorial siRNAs against HIV derived from one double hairpin RNA precursor. Front. Microbiol. 8, 1651 (2017).","journal-title":"Front. Microbiol."},{"key":"55793_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/1743-422X-8-295","volume":"8","author":"S Jahan","year":"2011","unstructured":"Jahan, S. et al. Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV. Virol. J. 8, 295 (2011).","journal-title":"Virol. J."},{"key":"55793_CR45","doi-asserted-by":"publisher","first-page":"41306","DOI":"10.18632\/oncotarget.9320","volume":"7","author":"Y Chen","year":"2016","unstructured":"Chen, Y. et al. microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K\/AKT pathway. Oncotarget 7, 41306\u201341319 (2016).","journal-title":"Oncotarget"},{"key":"55793_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010029","volume":"9","author":"HA Seo","year":"2019","unstructured":"Seo, H. A. et al. MicroRNA-based combinatorial cancer therapy: effects of microRNAs on the efficacy of anti-cancer therapies. Cells 9, 29 (2019).","journal-title":"Cells"},{"key":"55793_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49901-x","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Single dose of intravenous miR199a-5p delivery targeting ischemic heart for long-term repair of myocardial infarction. Nat. Commun. 15, 5565 (2024).","journal-title":"Nat. Commun."},{"key":"55793_CR48","doi-asserted-by":"publisher","first-page":"38323","DOI":"10.1021\/acsami.3c07541","volume":"15","author":"I Garrido-Cano","year":"2023","unstructured":"Garrido-Cano, I. et al. Delivery of miR-200c-3p using tumor-targeted mesoporous silica nanoparticles for breast cancer therapy. ACS Appl. Mater. Interfaces 15, 38323\u201338334 (2023).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"55793_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01654-7","volume":"8","author":"B Xu","year":"2023","unstructured":"Xu, B., Li, S., Shi, R. & Liu, H. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct. Target. Ther. 8, 435 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"55793_CR50","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1021\/acsabm.0c00814","volume":"3","author":"MB Mukherjee","year":"2020","unstructured":"Mukherjee, M. B., Mullick, R., Reddy, B. U., Das, S. & Raichur, A. M. Galactose functionalized mesoporous silica nanoparticles as delivery vehicle in the treatment of Hepatitis C infection. ACS Appl. Bio Mater. 3, 7598\u20137610 (2020).","journal-title":"ACS Appl. Bio Mater."},{"key":"55793_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes, B. B. et al. Nanodelivery of nucleic acids. Nat. Rev. Methods Primer 2, 24 (2022).","journal-title":"Nat. Rev. Methods Primer"},{"key":"55793_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030428","volume":"13","author":"JD Torres-Vanegas","year":"2021","unstructured":"Torres-Vanegas, J. D., Cruz, J. C. & Reyes, L. H. Delivery systems for nucleic acids and proteins: Barriers, cell capture pathways and nanocarriers. Pharmaceutics 13, 428 (2021).","journal-title":"Pharmaceutics"},{"key":"55793_CR53","volume":"26","author":"A Sani","year":"2021","unstructured":"Sani, A., Cao, C. & Cui, D. Toxicity of gold nanoparticles (AuNPs): A review. Biochem. Biophys. Rep. 26, 100991 (2021).","journal-title":"Biochem. Biophys. Rep."},{"key":"55793_CR54","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S90887","author":"G Tai","year":"2015","unstructured":"Tai, G. et al. Cytotoxicity of various types of gold-mesoporous silica nanoparticles in human breast cancer cells Int. J. Nanomed. https:\/\/doi.org\/10.2147\/IJN.S90887 (2015).","journal-title":"J. Nanomed."},{"key":"55793_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030118","volume":"10","author":"R Narayan","year":"2018","unstructured":"Narayan, R., Nayak, U. Y., Raichur, A. M. & Garg, S. Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances. Pharmaceutics 10, 118 (2018).","journal-title":"Pharmaceutics"},{"key":"55793_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10010110","volume":"10","author":"M Krzyzowska","year":"2022","unstructured":"Krzyzowska, M. et al. Lactoferrin-functionalized noble metal nanoparticles as new antivirals for HSV-2 infection. Microorganisms 10, 110 (2022).","journal-title":"Microorganisms"},{"key":"55793_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtice.2020.07.008","volume":"112","author":"N Saman","year":"2020","unstructured":"Saman, N., Othman, N. S., Chew, L.-Y., Mohd Setapar, S. H. & Mat, H. Cetyltrimethylammonium bromide functionalized silica nanoparticles (MSN) synthesis using a combined sol-gel and adsorption steps with enhanced adsorption performance of oxytetracycline in aqueous solution. J. Taiwan Inst. Chem. Eng. 112, 67\u201377 (2020).","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"55793_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ma15010327","volume":"15","author":"A Dedeloudi","year":"2022","unstructured":"Dedeloudi, A., Siamidi, A., Pavlou, P. & Vlachou, M. Recent advances in the excipients used in modified release vaginal formulations. Materials 15, 327 (2022).","journal-title":"Materials"},{"key":"55793_CR59","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1016\/j.apsb.2024.06.015","volume":"14","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y. et al. Transepithelial transport of nanoparticles in oral drug delivery: from the perspective of surface and holistic property modulation. Acta Pharm. Sin. B 14, 3876\u20133900 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"55793_CR60","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1021\/acs.molpharmaceut.0c01238","volume":"18","author":"MCP Mendon\u00e7a","year":"2021","unstructured":"Mendon\u00e7a, M. C. P., Kont, A., Aburto, M. R., Cryan, J. F. & O\u2019Driscoll, C. M. Advances in the design of (nano)formulations for delivery of antisense oligonucleotides and small interfering RNA: focus on the central nervous system. Mol. Pharm. 18, 1491\u20131506 (2021).","journal-title":"Mol. Pharm."},{"key":"55793_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd6740","volume":"7","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Injectable hydrogel with MSNs\/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs. Sci. Adv. 7, eabd6740 (2021).","journal-title":"Sci. Adv."},{"key":"55793_CR62","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1021\/nn900918w","volume":"3","author":"T Xia","year":"2009","unstructured":"Xia, T. et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3, 3273\u20133286 (2009).","journal-title":"ACS Nano"},{"key":"55793_CR63","first-page":"761","volume":"15","author":"S Andrade","year":"2022","unstructured":"Andrade, S. et al. Multi-dose intravenous administration of neutral and cationic liposomes in mice: an extensive toxicity study. Pharm. Basel Switz. 15, 761 (2022).","journal-title":"Pharm. Basel Switz."},{"key":"55793_CR64","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.4049\/jimmunol.167.4.2202","volume":"167","author":"SR Paludan","year":"2001","unstructured":"Paludan, S. R., Ellermann-Eriksen, S., Kruys, V. & Mogensen, S. C. Expression of TNF-\u03b1 by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF-\u03baB and activating transcription factor 2\/Jun and translational regulation through the AU-rich region of the 3\u2032 untranslated region. J. Immunol. 167, 2202\u20132208 (2001).","journal-title":"J. Immunol."},{"key":"55793_CR65","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.4049\/jimmunol.1401706","volume":"194","author":"V Marsden","year":"2015","unstructured":"Marsden, V. et al. Herpes Simplex Virus Type 2\u2013infected dendritic cells produce TNF-\u03b1, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells. J. Immunol. 194, 4438\u20134445 (2015).","journal-title":"J. Immunol."},{"key":"55793_CR66","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1128\/JVI.75.17.8008-8015.2001","volume":"75","author":"SR Paludan","year":"2001","unstructured":"Paludan, S. R. Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J. Virol. 75, 8008\u20138015 (2001).","journal-title":"J. Virol."},{"key":"55793_CR67","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1128\/JVI.01302-12","volume":"87","author":"M Stefanidou","year":"2013","unstructured":"Stefanidou, M. et al. Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy. J. Virol. 87, 1443\u20131453 (2013).","journal-title":"J. Virol."},{"key":"55793_CR68","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/ijms21010337","volume":"21","author":"D Vitali","year":"2020","unstructured":"Vitali, D. et al. Curcumin can decrease tissue inflammation and the severity of HSV-2 infection in the female reproductive mucosa. Int. J. Mol. Sci. 21, 337 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"55793_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.936235","volume":"13","author":"JB Smith","year":"2022","unstructured":"Smith, J. B., Herbert, J. J., Truong, N. R. & Cunningham, A. L. Cytokines and chemokines: the vital role they play in herpes simplex virus mucosal immunology. Front. Immunol. 13, 936235 (2022).","journal-title":"Front. Immunol."},{"key":"55793_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-022-01814-1","volume":"19","author":"S Montazersaheb","year":"2022","unstructured":"Montazersaheb, S. et al. COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 19, 92 (2022).","journal-title":"Virol. J."},{"key":"55793_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi, M. et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct. Target. Ther. 9, 176 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"55793_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed9010013","volume":"9","author":"AA Al-Qahtani","year":"2024","unstructured":"Al-Qahtani, A. A., Alhamlan, F. S. & Al-Qahtani, A. A. Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: A comprehensive review. Trop. Med. Infect. Dis. 9, 13 (2024).","journal-title":"Trop. Med. Infect. Dis."},{"key":"55793_CR73","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9, 7204\u20137218 (2018).","journal-title":"Oncotarget"},{"key":"55793_CR74","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","volume":"180","author":"KN Couper","year":"2008","unstructured":"Couper, K. N., Blount, D. G. & Riley, E. M. IL-10: The master regulator of immunity to infection. J. Immunol. 180, 5771\u20135777 (2008).","journal-title":"J. Immunol."},{"key":"55793_CR75","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/glia.20045","volume":"47","author":"CP Marques","year":"2004","unstructured":"Marques, C. P. et al. Interleukin\u201010 attenuates production of HSV\u2010induced inflammatory mediators by human microglia. Glia 47, 358\u2013366 (2004).","journal-title":"Glia"},{"key":"55793_CR76","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2249.2004.02342.x","volume":"135","author":"F Driessler","year":"2003","unstructured":"Driessler, F., Venstrom, K., Sabat, R., Asadullah, K. & Schottelius, A. J. Molecular mechanisms of interleukin-10-mediated inhibition of NF- \u03ba B activity: a role for p50. Clin. Exp. Immunol. 135, 64\u201373 (2003).","journal-title":"Clin. Exp. Immunol."},{"key":"55793_CR77","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00342-18","volume":"9","author":"LD Aarreberg","year":"2018","unstructured":"Aarreberg, L. D. et al. Interleukin-1\u03b2 signaling in dendritic cells induces antiviral interferon responses. mBio 9, e00342-18 (2018).","journal-title":"mBio"},{"key":"55793_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.crimmu.2023.100062","volume":"4","author":"R Chaudhary","year":"2023","unstructured":"Chaudhary, R., Meher, A., Krishnamoorthy, P. & Kumar, H. Interplay of host and viral factors in inflammatory pathway mediated cytokine storm during RNA virus infection. Curr. Res. Immunol. 4, 100062 (2023).","journal-title":"Curr. Res. Immunol."},{"key":"55793_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-019-0101-5","volume":"39","author":"N Kaneko","year":"2019","unstructured":"Kaneko, N., Kurata, M., Yamamoto, T., Morikawa, S. & Masumoto, J. The role of interleukin-1 in general pathology. Inflamm. Regen. 39, 12 (2019).","journal-title":"Inflamm. Regen."},{"key":"55793_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008335","volume":"16","author":"W Wang","year":"2020","unstructured":"Wang, W. et al. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathog. 16, e1008335 (2020).","journal-title":"PLoS Pathog."},{"key":"55793_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121823","volume":"9","author":"L Gedefaw","year":"2021","unstructured":"Gedefaw, L., Ullah, S., Lee, T. M. H., Yip, S. P. & Huang, C.-L. Targeting inflammasome activation in COVID-19: Delivery of RNA interference-based therapeutic molecules. Biomedicines 9, 1823 (2021).","journal-title":"Biomedicines"},{"key":"55793_CR82","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a013011","volume":"4","author":"SK Weller","year":"2012","unstructured":"Weller, S. K. & Coen, D. M. Herpes simplex viruses: mechanisms of DNA replication. Cold Spring Harb. Perspect. Biol. 4, a013011 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"55793_CR83","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1073\/pnas.1817642116","volume":"116","author":"S Weerasooriya","year":"2019","unstructured":"Weerasooriya, S., DiScipio, K. A., Darwish, A. S., Bai, P. & Weller, S. K. Herpes simplex virus 1 ICP8 mutant lacking annealing activity is deficient for viral DNA replication. Proc. Natl. Acad. Sci. U. S. A. 116, 1033\u20131042 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"55793_CR84","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/jvi.65.5.2666-2675.1991","volume":"65","author":"M Gao","year":"1991","unstructured":"Gao, M. & Knipe, D. M. Potential role for Herpes simplex virus ICP8 DNA replication protein in stimulation of late gene expression. J. Virol. 65, 2666\u20132675 (1991).","journal-title":"J. Virol."},{"key":"55793_CR85","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.virol.2015.04.005","volume":"483","author":"S Luo","year":"2015","unstructured":"Luo, S. et al. Contribution of N-linked glycans on HSV-2 gB to cell\u2013cell fusion and viral entry. Virology 483, 72\u201382 (2015).","journal-title":"Virology"},{"key":"55793_CR86","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1128\/JVI.00011-11","volume":"85","author":"DC Johnson","year":"2011","unstructured":"Johnson, D. C., Wisner, T. W. & Wright, C. C. Herpes simplex virus glycoproteins gB and gD function in a redundant fashion to promote secondary envelopment. J. Virol. 85, 4910\u20134926 (2011).","journal-title":"J. Virol."},{"key":"55793_CR87","doi-asserted-by":"publisher","first-page":"12277","DOI":"10.1074\/jbc.M111.331777","volume":"287","author":"P Malik","year":"2012","unstructured":"Malik, P. et al. Herpes simplex virus ICP27 protein directly interacts with the nuclear pore complex through Nup 62, inhibiting host nucleocytoplasmic transport pathways. J. Biol. Chem. 287, 12277\u201312292 (2012).","journal-title":"J. Biol. Chem."},{"key":"55793_CR88","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fimmu.2019.00290","volume":"10","author":"X Guan","year":"2019","unstructured":"Guan, X., Zhang, M., Fu, M., Luo, S. & Hu, Q. Herpes simplex virus type 2 immediate early protein ICP27 inhibits IFN-\u03b2 production in mucosal epithelial cells by antagonizing IRF3 activation. Front. Immunol. 10, 290 (2019).","journal-title":"Front. Immunol."},{"key":"55793_CR89","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1365-4632.2010.04732.x","volume":"50","author":"G Qing","year":"2011","unstructured":"Qing, G. et al. Research of UL54\u2010specific siRNA on herpes simplex virus Type II replication. Int. J. Dermatol. 50, 362\u2013366 (2011).","journal-title":"Int. J. Dermatol."},{"key":"55793_CR90","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nm.3103","volume":"19","author":"JT Schiffer","year":"2013","unstructured":"Schiffer, J. T. & Corey, L. Rapid host immune response and viral dynamics in herpes simplex virus-2 infection. Nat. Med. 19, 280\u2013290 (2013).","journal-title":"Nat. Med."},{"key":"55793_CR91","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1128\/JVI.01845-15","volume":"90","author":"K Wang","year":"2016","unstructured":"Wang, K. et al. A herpes simplex virus 2 (HSV-2) gD mutant impaired for neural tropism is superior to an HSV-2 gD subunit vaccine to protect animals from challenge with HSV-2. J. Virol. 90, 562\u2013574 (2016).","journal-title":"J. Virol."},{"key":"55793_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/jfb14010012","volume":"14","author":"C Zhao","year":"2022","unstructured":"Zhao, C. & Zhou, B. Polyethyleneimine-based drug delivery systems for cancer theranostics. J. Funct. Biomater. 14, 12 (2022).","journal-title":"J. Funct. Biomater."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55793-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55793-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55793-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T01:03:01Z","timestamp":1787187781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55793-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55793"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55793-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were reviewed and approved by the Institutional Animal Ethics Committee (IAEC), RPMC-University of Calcutta, under CPCSEA (Committee for the Purpose of Control and Supervision of Experiments on Animals, Govt. of India) registration No. 1148\/PO\/Re\/S\/07\/CPCSEA, with Study Protocol No. IAEC\/RPMC\/2022\/5. The animal experimental procedures were performed in accordance with the ARRIVE (Animal Research: Reporting of\u00a0\n                      In Vivo\n                      \u00a0Experiments) guidelines and applicable regulations. Animals were humanely euthanized after completion of the experiments in compliance with the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals (2020).","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26145"}}